Abstract
Visceral leishmaniasis is a severe form of infection caused by a parasite endemic along the Mediterranean coast. Complications such as infection-associated hemophagocytic syndrome can occur despite correct therapy. We report visceral leishmaniasis-associated infection-associated hemophagocytic syndrome in 3 patients with chronic granulomatous disease.
MeSH terms
-
Adolescent
-
Amphotericin B / therapeutic use
-
Animals
-
Antiprotozoal Agents / therapeutic use
-
Child
-
Fatal Outcome
-
Female
-
Granulomatous Disease, Chronic / complications*
-
Humans
-
Interferon-gamma / therapeutic use
-
Leishmaniasis, Visceral / complications*
-
Leishmaniasis, Visceral / diagnosis
-
Leishmaniasis, Visceral / drug therapy
-
Lymphohistiocytosis, Hemophagocytic / complications*
-
Lymphohistiocytosis, Hemophagocytic / diagnosis
-
Lymphohistiocytosis, Hemophagocytic / etiology
-
Male
-
Recombinant Proteins
Substances
-
Antiprotozoal Agents
-
Recombinant Proteins
-
liposomal amphotericin B
-
Amphotericin B
-
Interferon-gamma